Staff Profile
Julie Diboll
Research Technician
- Email: julie.diboll@ncl.ac.uk
- Telephone: +44 (0) 191 208 2789
- Personal Website: http://www.ncl.ac.uk/biomedicine/research/groups/musculoskeletal.htm
- Address: Newcastle University
Institute of Cellular Medicine
Musculoskeletal Research Group (Immunotherapy)
3rd Floor Leech Building
The Medical School
Framlington Place
Newcastle upon Tyne
NE2 4HH
Publications
- Ward C, Eger K, Diboll J, Jones D, Haniffa MA, Fisher A, Brodlie M, Lordan JL, Corris PA, Hilkens CM. Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells. Thorax 2009, 64(5), 430-435.
- Anderson AE, Sayers BL, Haniffa MA, Swan DJ, Diboll J, Wang XN, Isaacs JD, Hilkens CMU. Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells. Journal of Leukocyte Biology 2008, 84(1), 124-133.
- Fullard N, Moles A, O'Reilly S, van Laar JM, Faini D, Diboll J, Reynolds NJ, Mann DA, Reichelt J, Oakley F. The c-Rel Subunit of NF-κB Regulates Epidermal Homeostasis and Promotes Skin Fibrosis in Mice. American Journal of Pathology 2013, 182(6), 2109-2120.
- Anderson AE, Lorenzi AR, Pratt A, Wooldridge T, Diboll J, Hilkens CM, Isaacs JD. Immunity 12 years after alemtuzumab in RA: CD5+ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses. Rheumatology 2012, 51(8), 1397-1406.
- Sayers B, Haniffa M, Diboll J, Isaacs J, Hilkens C. Generation of dexamethasone and vitamin D3-treated human monocyte-derived dendritic cells with tolerogenic properties. In: Arthritis Research & Therapy: 6th Global Arthritis Research Network Meeting (GARN). 2007, Zurich, Switzerland: BioMed Central Ltd.
- Khan ZJ, Diboll J, Baldwin CI, Calvert JE. Pigeon fanciers' lung: complement activation by antigens and immune complexes. In: Joint Congress of the British Society for Immunology and the British Society for Allergy and Clinical Immunology. 1999, Harrogate, UK: Wiley-Blackwell Publishing Ltd.
- Bell GM, Anderson AE, Diboll J, Reece R, Eltherington O, Harry RA, Fouweather T, MacDonald C, Chadwick T, McColl EM, Dunn J, Dickinson AM, Hilkens CMU, Isaacs JD. Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases 2017, 76(1), 227-234.
- McGovern A, Schoenfelder S, Martin P, Massey J, Duffus K, Plant D, Yarwood A, Pratt AG, Anderson AE, Isaacs JD, Diboll J, Thalayasingam N, Ospelt C, Barton A, Worthington J, Fraser P, Eyre S, Orozco G. Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23. Genome Biology 2016, 17, 212.
- Pratt AG, Massey J, Anderson AE, Nair N, Diboll J, Skelton A, Lendrem DW, Reynard LN, Cordell HJ, Eyre S, Barton A, Isaacs JD. Identification of novel expression quantitative trait loci in CD4+ T cells of untreated early arthritis patients. In: 36th European Workshop for Rheumatology Research. 2016, York: BMJ Group.
- Lord P, Spiering R, Aguillón JC, Anderson AE, Appel S, Benitez-Ribas D, ten-Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van-Ham SM, Lattimer S, Marshall L, Harry RA, Hutchinson JA, Isaacs JD, Joosten I, van-Kooten C, López-Díaz-de-Cerio A, Nikolic T, Barbaros-Oral H, Sofronic-Milosavljevic L, Ritter T, Riquelme P, Thomson AW, Trucco M, Vives-Pi M, Martinez-Caceres E, Hilkens CM. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies. PeerJ 2016, 4, 1-14.
- Hilkens C, Anderson A, Harry R, Bell G, Diboll J, Stoop J, Dunn J, McColl E, Dickinson A, Isaacs J. A Dendritic Cell-Based Therapy for Rheumatoid Arthritis. In: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2015, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL.
- Pratt AG, Anderson AE, Lendrem DW, Skelton A, Massey J, Nair N, Diboll J, Hargreaves B, Brown PM, Barton A, Isaacs JD. STAT3-regulated gene expression in circulating CD4+ T cells discriminates RA patients independently of clinical parameters in early arthritis: a validation study. In: 2015 ACR/ARHP Annual Meeting. 2015, San Francisco, CA.
- Pratt AG, Anderson AE, Nair N, Massey J, Diboll J, Skelton A, Hargreaves B, Routledge C, Lendrem D, Brown P, Barton A, Isaacs JD. The Importance of IL-6-STAT3 Mediated Activation of Circulating CD4+ T Cells in the Pathogenesis of Early Seronegative Rheumatoid Arthritis: A Validation Study. In: Rheumatology 2015. 2015, Manchester, UK: Oxford University Press.
- Bell G, Anderson AE, Diboll J, Harry R, McColl E, Dickinson A, Hilkens C, Isaracs JD. Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis. In: ACR/ARHP Annual Meeting. 2014, Boston, MA, USA: Wiley-Blackwell Publishing Ltd.
- Bell G, Anderson A, Harry R, Diboll J, McColl E, Dickinson A, Hilkens C, Isaacs JD. Autologous tolerogenic dendritic cells in rheumatoid and inflammatory arthritis. In: European Workshop for Rheumatology Research. 2014, Lisbon, Portugal: BMJ Publishing Group Ltd.
- Bell G, Anderson A, Diboll J, Harry R, McColl E, Dickinson A, Hilkens C, Isaacs J. Autologous Tolerogenic Dendritic Cells In Rheumatoid and Inflammatory Arthritis. In: Arthritis & Rheumatism 2013 Annual Meeting. 2013, San Diego, CA, USA: John Wiley & Sons, Inc.
- Thalayasingam N, Nair N, Skelton AJ, Massey J, Anderson AE, Clark AD, Diboll J, Lendrem DW, Reynard LN, Cordell HJ, Eyre S, Isaacs JD, Barton A, Pratt AG. CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification. Arthritis and Rheumatology 2018, 70(3), 361-370.
- Cope AP, Barnes MR, Belson A, Binks M, Brockbank S, Bonachela-Capdevila F, Carini C, Fisher BA, Goodyear CS, Emery P, Ehrenstein MR, Gozzard N, Harris R, Hollis S, Keidel S, Levesque M, Lindholm C, McDermott MF, McInnes IB, Mela CM, Parker G, Read S, Pedersen AW, Ponchel F, Porter D, Rao R, Rowe A, Schulze-Knappe P, Sleeman MA, Symmons D, Taylor PC, Tom B, Tsuji W, Verbeeck D, Isaacs JD, Anderson A, Stocks P, Lendrem D, Tarn J, Smith G, Casement J, Diboll J, Harry R, Simpson G, Toward R, Noble H, Parke A, Wu W, Clarke F, Scott D, Scott IC, Galloway J, Lempp H, Ibrahim F, Schwank S, Molyneux G, Lazarov T, Geissmann F, Donnelly I, Gilmour A, TulunayVirlan A, El-Jawhari J, Parmer R, Buch M, Buckley C, Young S, Jones P, Raza K, Filer A, Pitzalis C, Thorborn G, Fossati-Jimack L, Kelly S, Humby F, Novak T, Rana S, Goldmann K, Lewis M, Watson D, Jia Z, Altobelli G, John C, Martins S, Nguyen D, Ali H, Worthington J, Bruce I, Sergeant J, Verstappen S, D'Costa N, Stirling F, Hughes-Morley A, Farewell V, Zhong Y, Cuff C, Long A, Liu Z, Lipsky S, Harvey B, MacOritto M, Hong F, Kaymakcalan S, Sabin T, Ward N, Talbot S, Padhi D, Finch D, Herath A, Jenkins M, Ho M, Marshall C, Page M, Edwards H, Cuza A, Loza M, Curran M, Baker D, Vranic I, Mela CT, Wright S, Rowell L, Vernon E, Joseph N, Payne N, Ludbrook V, Hicks K, Tipney H, Ellis J, Hasan S, Didierlaurent A, Burny W, Haynes A, Larminie C, Dastros-Pitel D, Kola B, Jelinksy S, Hodge M, MacIejewski M, Ziemek D, Zucht H-D, Budde P. The RA-MAP Consortium: a working model for academia-industry collaboration. Nature Reviews Rheumatology 2018, 14(1), 53-60.
- Cooles FAH, Anderson AE, Drayton T, Harry RA, Diboll J, Munro L, Thalayasingham N, Ostor AJK, Isaacs JD. Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. Arthritis Research & Therapy 2016, 18, 302.